Tuberculosis after renal transplantation;Gruźlica po przeszczepieniu nerki

Pneumonologia i Alergologia Polska

Volumn 77, Issue 1, 2009, Pages 61-65

  Korzeniewska, Anna ^a   Dyta, Tomasz ^a   Kosacka, Monika ^a   Jankowska, Renata ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Immunosuppression; Renal transplantation; Tuberculosis

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TUBERCULOSTATIC AGENT;

GRAFT REJECTION; HEALTH; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; LUNG TUBERCULOSIS; PROGNOSIS; REVIEW; RISK FACTOR; TREATMENT OUTCOME; TUBERCULOSIS; UROGENITAL TUBERCULOSIS;

ANTITUBERCULAR AGENTS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS, PULMONARY; TUBERCULOSIS, UROGENITAL; WORLD HEALTH;

EID: 67649197383     PISSN: 08677077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Singh N., Paterson D. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin. Infect. Dis. 1998; 27: 1266-1277.
2. Vandermarliere A., Van Audenhove A., Peetermans W.E., Vanrenterghem Y., Maes B. Mycobacterial infection after renal transplantation in a Western population. Transplant. Infect. Dis. 2003; 5: 9-15.
3. Lezaic V., Radivojevic R., Radosavljevic G. i wsp. Does tuberculosis after kidney transplantation follow the trend of tuberculosis in general population? Renal Failure 2001; 1: 97-106.
4. European best practice guidlines far renal transplantation. Section IV: Lang-term management of the transplant recipient. IV.7.2. Late infections. Tuberculosis. Nephrol. Dial. Transplant. 2002; 17: 39-43.
5. Sayiner A., Ece T., Duman S. Tuberculosis in renal transplant recipients. Transplantation 1999; 9: 1268-1271.
6. Queipo J.A., Broseta E., Santos M., Sanchez-Plumed J., Budia A., Jimenez-Cruz F. Mycobacterial infection in a series of 1261 transplant recipients. Clin. Microbiol. Infect. 2003; 9: 518-525.
7. Jereb J.A., Burwen D.R., Dooley S.W. Nosocomial outbreak of tuberculosis in a renal transplant unit: application of a new technique for restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates. J. Infect. Dis. 1993; 168: 1219-1224.
8. Peters T.G., Reiter C.G., Boswell R.L. Transmission of tuberculosis by kidney transplantation. Transplantation 1984; 38: 514-516.
9. Durlik M., Klinger M., Lao M., Wiȩcek A., Rowiński W. Zalecenia dotycza̧ce leczenia immunosupresyjnego po przeszczepieniu narza̧dów unaczynionych. W: Rowiński W., Durlik M. (red.). Fundacja Zjednoczeni dla Transplantacji, Warszawa 2006; 13-47.
10. Chen C.H., Lian J.D., Cheng C.H., Wu M.J., Lee W.C., Shu K.H. Mycobacterium tuberculosis infection following renal transplantation in Taiwan. Transpl. Infect. Dis. 2006; 8: 148-156.
11. Higgins R.M., Cahn A.P., Porter D. i wsp. Mycobacterial infections after renal transplantation. Q. J. Med. 1991; 78: 145-153.
12. Kircher B., Latzer K., Gastl G., Nachbaur D. Comparative in vitro study of the immunomodulatory activity of humanized and chimeric anti-CD25 monoclonal antibodies. Clin. Exp. Immunol. 2003; 134: 426-430.
13. Van Gelder T., Warle M., Ter Meulen R.G. Anti-interleukin-2 receptar antibodies in transplantation: what is the basis for choice. Drugs 2004; 64: 1737-1741. (Pubitemid 39215185)
14. Qunibi W.Y., Al-Sibai B., Taher S. i wsp. Mycobacterial infections after renal transplantation-report of 14 cases and review of the literature. Q. J. Med. 1990; 77: 1039-1060.
15. Drobniewski F.A., Ferguson J. Tuberculosis in renal transplant units. Nephrol. Dial. Transplant. 1996; 11: 768-770.
16. Rowinska D., Durlik M., Gradowska L. i wsp. Gruźlica u chorych po przeszczepieniu nerki. Pneumonol. Alergol. Pol. 1994; 62: 272-279.
17. Apaydin S., Altiparmak M.R., Serdengecti K., Ataman R., Ozturk R., Erek E. Mycobacterium tuberculosis infections after renal transplantation. Scand. J. Infect. Dis. 2000; 32: 501-505.
18. Hall C.M., Willcox P.A., Swanepoel C.R., Kahn D., van Zyl Smit R. Mycobacterial infection in renal transplant recipients. Chest 1994; 2: 435-439. (Pubitemid 24252039)
19. Chou K.J., Fang H.C., Bai K.J., Hwang S.J., Yang W.C. Chung H.M. Tuberculosis in maintenance dialysis patients. Nephron 2001; 88: 138-143.
20. Fang H.C., Lee P.T., Chen C.L., Wu M.J., Chou K.J., Chung H.M. Tuberculosis in patients with end-stage renal disease. Int. J. Tuberc. Lung Dis. 2004; 8: 92-97.
21. Choong-San O., Stratta R.J., Fox B.C., Sollinger H.W., Belzer F.O., Maki D.G. Increased infections associated with the use of OKT3 for treatment of steroid-resistant rejection in renal transplantation. Transplantation 1988; 45: 68-73.
22. Green M., Avery R.K. Mycobacterium tuberculosis. Am. J. Transpl. 2004; 4 (supl. 10): 37-41.
23. Rowińska-Zakrzewska E., Kuś J. Choroby układu oddechowego. Wydawnictwo PZWL, Warszawa 2004; 548-551.
24. Cassidy M.J., Van Zyl-Smit R., Pascoe M.D., Swanepoel C.R., Jacobson J.E. Effect of rifampin on cyclosporin A blood levels in a renal transplant recipient. Nephron 1985; 41: 207-208. (Pubitemid 15226366)
25. Buffington G.A., Dominguez J.H., Piering W.F., Hebert L.A., Kaufmann H.M. Jr, Lemann J. Jr. Interaction of rifampin and glucocorticoids. Advers effect on renal allograft function. J. Am. Med. Assoc. 1976; 236: 1958-1960.
26. Aguado J.M., Herrero JA., Gavalda J. i wsp. Clinical presentation and outcome of tuberculosis in kidney, liver and heart transplant recipients in Spain. Transplantation 1997; 63: 1278-1286.
27. Lopez-Montes A., Gallego E., Lopez E. i wsp. Treatment of tuberculosis with rifabutin in a renal transplant recipient. Am. J. Kidney Dis. 2004; 4: 59-63.
28. Nolan C.M., Goldberg S.V., Buskin S.E. Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic. J. Am. Med. Assoc. 1999; 281: 1014-1018.
29. Periera B.J., Wright T.L., Schmidt C.H., Levey A.S. The impact pretransplantation of hepatitis C infection on the outcome of renal transplantation. Transplantation 1995; 60: 799.
30. Genesca J., Vila J., Cordoba J. i wsp. Hepatitis C virus infection in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication. J. Hepatol. 1995; 22: 272.
31. John G.T., Shankar V., Abraham A.M., Mukundan U., Punnakuzhat P., Jacob C.K. Risk factors for post-transplant tuberculosis. Kidney International 2001; 60: 1148-1153.
32. International Union Against Tuberculosis committee on prophylaxis efficacy of various durations of isoniazid preventive therapy for tuberculosis: 5 years of follow up in the IUAT trial. Bull. WHO 1982; 60: 555-564.
33. Pape J.W., Jean S.S., Ho J.L. iwsp. Effect of isoniazid prophylaxis on incidence of active TB and progression of HIV infection. Lancet 1993; 342: 268-272.
34. Whalen C.C., Johnson J.L., Okwera A. i wsp. A trial of three regimens to prevent tuberculosis in Ugandon adults infected with HIV. N. Engl. J. Med. 1997; 337: 801-808.
35. Agarwal S.K., Gupta S., Dash S.C., Bhowmik D., Tiwari S.C. Prospective randomized trial of isoniazid prophylaxis in renal transplant recipient. Int. Ur. Nephr. 2004; 36: 425-431.
36. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society, MMWR 2000; 49: 1-51.
37. Rowińska-Zakrzewska E. Gruźlica w praktyce lekarskiej. Wydawnictwo PZWL, Warszawa 2000; 242-245.
38. Kobasbi Y., Mauri K., Obase Y., Fukuda M., Miyashita N., Oka M. Clinical evaluation of Quantiferon TB-2G test for immunocompromised patients. Eur. Respir. J. 2007; 30: 945-950.